Inhibition of SCAP improves the sensitivity of sorafenib-resistant HCC cells, as SCAP is overexpressed in sorafenib-resistant HCC tissues and hepatoma cell lines (Li et al., 2022). This evidence concerns the gene SCAP and hepatocellular carcinoma.